SELE and neoplasm: Sialyl LewisX can serve as a tumor marker and alter cancer cell phenotypes by increasing cancer cell motility and proliferation through E-selectin–mediated cancer cell adhesion to vascular endothelial cells or E-selectin-independent pattern [44, 45].